Bausch + Lomb Corp

NYSE:BLCOUnited StatesView on Canadian Exchange

Bausch + Lomb Corporation is a Canada-based global eye health company. The Company’s Vision Care segment includes both a contact lens business and a consumer eye care business that consists of contact lens care products, over the counter (OTC) eye drops and eye vitamins. The Company’s Ophthalmic Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Its Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. The Company’s brands include PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, and many more.

Contact Information

Headquarters

520 Applewood CrescentVAUGHAN, ON, Canada L4K 4B4

Phone

---

Fax

---

Executives

Chairman of the Board, Chief Executive Officer

Brenton Saunders

Chief Financial Officer, Executive Vice President

Sam Eldessouky

President of Ophthalmic Pharmaceuticals

Andrew Stewart

Executive Vice President, Chief Legal Officer

A. Robert Bailey

Executive Vice President - Research & Development, Chief Medical Officer

Yehia Hashad